Benefits of laparoscopic surgery for bleeding events in patients with implantable left ventricular assist devices during antithrombotic therapy
Aya Nakae, Michiko Kodama, Eiji Kobayashi and 3 more
Gynecology and Minimally Invasive Therapy · 2022
doi:10.4103/gmit.gmit_35_21 (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
Hemorrhagic ovarian cysts (HOCs), a common gynecological disease causing intraabdominal bleeding, can be life threatening in patients undergoing antithrombotic therapy, especially those with left ventricular assist device (LVAD) implantation under strong antithrombotic therapy. We encountered three postLVAD implantation cases with intraabdominal bleeding due to suspected HOCs, which required surgery for hemostasis. Such patients are not only at a higher risk of bleeding but also have restrictions in available surgical incision sites to avoid damaging the LVAD driveline located underneath the abdominal wall. Laparoscopic surgery, which can be performed through minute incisions with flexible site selection, may benefit intraabdominal hemorrhage patients with LVADs.
Abstract licence: CC BY-NC-SA
References10
10 more references, whose wording the paper’s licence keeps private.
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.